CHIRICOZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 7.518
AS - Asia 931
EU - Europa 889
Continente sconosciuto - Info sul continente non disponibili 204
SA - Sud America 132
AF - Africa 23
OC - Oceania 3
Totale 9.700
Nazione #
US - Stati Uniti d'America 7.456
SG - Singapore 375
CN - Cina 235
IT - Italia 163
RU - Federazione Russa 144
BR - Brasile 108
DE - Germania 95
UA - Ucraina 84
FR - Francia 80
HK - Hong Kong 77
VN - Vietnam 67
SE - Svezia 63
GB - Regno Unito 61
IE - Irlanda 55
PL - Polonia 44
CA - Canada 40
BD - Bangladesh 38
IN - India 37
FI - Finlandia 29
NL - Olanda 25
JP - Giappone 24
KR - Corea 19
ES - Italia 11
AR - Argentina 10
MX - Messico 8
TR - Turchia 8
CO - Colombia 7
MY - Malesia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
PH - Filippine 6
RO - Romania 6
CH - Svizzera 5
ID - Indonesia 5
KG - Kirghizistan 5
LT - Lituania 5
MA - Marocco 4
PK - Pakistan 4
AU - Australia 3
BE - Belgio 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
NI - Nicaragua 3
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
JM - Giamaica 2
OM - Oman 2
RS - Serbia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GP - Guadalupe 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 9.501
Città #
Woodbridge 2.027
Wilmington 1.736
Houston 1.515
Ashburn 254
Singapore 252
Fairfield 218
Chandler 145
Ann Arbor 126
San Jose 106
Seattle 83
Hong Kong 77
Cambridge 76
Beijing 68
Jacksonville 68
Dearborn 64
New York 63
Dublin 54
Council Bluffs 50
Medford 45
Rome 39
Kraków 37
The Dalles 37
Santa Clara 36
Zhengzhou 36
Los Angeles 31
Dallas 25
Ho Chi Minh City 24
Tokyo 24
Buffalo 23
Lawrence 21
Hanoi 18
Lauterbourg 18
São Paulo 16
Milan 15
Moscow 15
Munich 15
San Diego 15
Toronto 14
Amsterdam 13
Menlo Park 12
Montreal 12
Denver 11
Norwalk 11
Redondo Beach 10
Chicago 9
Shanghai 9
Helsinki 8
Palo Alto 8
Brooklyn 7
Columbus 7
Dhaka 7
Hefei 7
Nanjing 7
Philadelphia 7
Poplar 7
Warsaw 7
Boardman 6
Chennai 6
Detroit 6
Frankfurt am Main 6
Johannesburg 6
Kunming 6
London 6
Orem 6
Mumbai 5
Phoenix 5
Bari 4
Engelhard 4
Fuzhou 4
Nanchang 4
Naples 4
Newark 4
North Bergen 4
Redwood City 4
San Antonio 4
The Bronx 4
Verona 4
Boston 3
Brussels 3
Catania 3
Elk Grove Village 3
Esslingen am Neckar 3
Florence 3
Fortaleza 3
Goiânia 3
Guangzhou 3
Indianapolis 3
Ludhiana 3
Managua 3
Manchester 3
Mexico City 3
Paris 3
Pune 3
Salt Lake City 3
Trieste 3
Turin 3
Vienna 3
Accra 2
Ankara 2
Araguari 2
Totale 7.813
Nome #
Efficacy and safety of infliximab in psoriatic patients over the age of 65 565
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 553
Apremilast for the treatment of psoriasis. 499
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 497
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 468
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 466
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 457
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 435
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 429
Quality-of-life impairment in hidradenitis suppurativa 427
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 422
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 410
Immunologic biomarkers for clinical and therapeutic management of psoriasis 390
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 382
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 378
Tofacitinib for the treatment of moderate-to-severe psoriasis 371
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 355
Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study 347
Assessement of disease severity and treatment effectiveness in hidradenitis suppurtiva 346
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 346
Alexithymia affects patients with hidradenitis suppurativa 321
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 144
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 130
Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab 112
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 104
Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa 104
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 93
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 75
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 74
Totale 9.700
Categoria #
all - tutte 23.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 0 13 8 19 10 8 14 20 17 46
2022/2023323 27 29 15 49 29 66 24 18 36 3 13 14
2023/2024177 19 1 10 5 13 39 8 16 4 15 7 40
2024/2025614 23 133 65 66 14 41 73 30 35 55 55 24
2025/20261.188 94 50 141 153 106 30 149 148 113 98 53 53
2026/2027469 81 45 207 136 0 0 0 0 0 0 0 0
Totale 9.700